Corporate Banner
Satellite Banner
Mass Spectrometry
Scientific Community
Become a Member | Sign in
Home>News>This Article

908 Devices Introduces World’s First Handheld Mass Spectrometer

Published: Tuesday, March 11, 2014
Last Updated: Tuesday, March 11, 2014
Bookmark and Share
M908 uses patented high-pressure mass spectrometry to enhance detection and identification capabilities for first responders.

908 Devices has introduced M908™, the world’s first truly handheld tool utilizing high-pressure mass spectrometry™ (HPMS). Specifically engineered for civilian users, first responders, and military teams, M908 provides accurate, immediate detection and identification of trace level chemical and explosive hazards at the point-of-action.

Conventional mass spectrometers (MS) are typically confined to centralized laboratories by their large size, fragility and complexity of operation and maintenance.

Early efforts at shrinking MS lead to luggable mass spec systems however, these instruments remain large and fragile resulting in limited deployment.

908 Devices is the first to deliver MS capability in a truly rugged and handheld form factor dramatically expanding first responder capabilities. Unlike any other MS, M908 weighs less than 2kg (4.4 lbs) and is battery powered for continuous operation in the field.

It has been designed to meet commercial and military standards (MIL-STD-810G); which require repeated drops onto concrete and metal, storage and operation in extreme hot and cold conditions, and ingress protection to dust and water.

The patented HPMS technology which powers M908 uses diminutive ion traps that measure less than a millimeter in diameter and that are capable of operation at 10,000 times higher pressure than those in conventional MS systems. This enables the use of small, rugged vacuum pumps, micro ionizers, detectors and efficient electronics.

“At 908 Devices we believe in solving specific problems, creating unique tools rather than general purpose instruments that do anything - but nothing quite that well. M908 is our first fit-for-purpose product line built on this philosophy,” says Dr. Kevin J. Knopp, co-founder and chief executive officer at 908 Devices. “We have received a very positive initial response to M908 and look forward to even broader applications with the technology.”

At the core of HPMS is seminal intellectual property of micro mass spectrometry developed by 908 Devices’ Science Founder, Dr. J. Michael Ramsey; the Minnie N. Goldby Distinguished Professor of Chemistry at the University of North Carolina, Chapel Hill.

The research conducted by Ramsey’s group on micro MS began at Oak Ridge National Labs and continued at UNC. This is an on-going program that has invested $17.5M in support from DOE, DARPA, and DTRA.

This HPMS technology has already been recognized by the scientific community, winning The Analytical Scientist Innovation Award in 2013 and demonstrating the impact that small, simple and robust mass spec devices will have.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

908 Devices Announces Significant Milestones
Company has expanded its office from a 7,000 square-foot R&D think tank into a 16,000 square-foot full-scale production facility.
Wednesday, August 20, 2014
908 Devices Receives $7 Million in Series B Funding
The financing round will be used to expand the R&D team and to accelerate and commercialize 908 Devices’ initial safety and security products.
Wednesday, September 11, 2013
908 Devices’ Research Partner Presents Research on Mass Spectrometry
Advancing the rapidly evolving field of High Pressure Mass Spectrometry.
Friday, August 16, 2013
Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
New Method Identifies Up to Twice as Many Proteins and Peptides
An international team of researchers developed a method that identifies up to twice as many proteins and peptides in mass spectrometry data than conventional approaches.
Metabolic Profiles Distinguish Early Stage Ovarian Cancer with Unprecedented Accuracy
Studying blood serum compounds of different molecular weights has led scientists to a set of biomarkers that may enable development of a highly accurate screening test for early-stage ovarian cancer.
Acetaldehyde and Formaldehyde Content in Foods
Korean researchers have determined the content of the toxic and carcinogenic aldehydes, acetaldehyde and formaldehyde, in a variety of food groups.
Combining the Power of Mass Spectrometry & Microscopy
A tool that provides world-class microscopy and spatially resolved chemical analysis shows considerable promise for advancing a number of areas of study, including chemical science, pharmaceutical development and disease progression.
Increasing Vitamin D Supplementation
New study from ETH Zurich finds that elderly women should consume more vitamin D than previously recommended during the winter months.
Advancing Lithium-Ion Battery Research
The increasing number of components in a lithium-ion battery makes it essential to use a variety of analytical methods to attain complete characterization.
Clearest Ever Images of Enzyme that Plays Key Roles in Aging, Cancer
UCLA-led research on telomerase could lead to new strategies for treating disease
Fruit Fly Pheromone Flags Great Real Estate for Starting a Family
Finding could aid efforts to control mosquito-borne diseases like malaria by manipulating odorants
Education and Expense: The Barriers to Mass Spectrometry in Clinical Laboratories?
Here we examine the perceived barriers to mass spec in clinical laboratories and explore the possible drivers behind the recent shift in uptake of the technology in clinical settings.
Scroll Up
Scroll Down
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos